Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-17T10:06:25.559Z Has data issue: false hasContentIssue false

Small cell carcinoma of the head and neck: report of three cases

Published online by Cambridge University Press:  08 August 2013

H Matsuyama*
Affiliation:
Department of Otolaryngology, Faculty of Medicine, Niigata University, Japan
K Yamazaki
Affiliation:
Department of Otolaryngology, Faculty of Medicine, Niigata University, Japan
M Tomita
Affiliation:
Department of Otolaryngology, Faculty of Medicine, Niigata University, Japan
S Takahashi
Affiliation:
Department of Otolaryngology, Faculty of Medicine, Niigata University, Japan
*
Address for correspondence: Dr Hiroshi Matsuyama, Department of Otolaryngology, Niigata University, Faculty of Medicine, 1-757 Asahimachi-dori, Chuo-ku, Niigata-shi 951-8510, Japan Fax: +81 25 227 0786 E-mail: matsuhiroshi@med.niigata-u.ac.jp
Rights & Permissions [Opens in a new window]

Abstract

Objective:

Small cell carcinoma of the head and neck is rare and has unique histopathological characteristics that make it difficult to diagnose and treat. In this report, the Japanese Lung Cancer Treatment Guidelines were adapted to treat three patients with small cell carcinoma of the head and neck, and outcomes evaluated.

Methods:

There was one case each of stage I small cell carcinoma of the nasal cavity, stage IV-B small cell carcinoma of the ethmoid sinus, and stage IV-A small cell carcinoma of the submandibular gland. All patients underwent chemoradiotherapy and achieved a partial response.

Results:

Only case one underwent surgery after chemoradiotherapy; 31 months after treatment, this patient had suffered no recurrence. Case two died three months after treatment due to bone marrow metastasis. Case three had experienced no progression after 12 months of follow up.

Conclusion:

In this small patient series, short-term results were equivalent to or better than usual treatment outcomes for small cell carcinoma of the lung.

Information

Type
Clinical Records
Copyright
Copyright © JLO (1984) Limited 2013 
Figure 0

Fig. 1Imaging studies for case one. (a) Axial, gadolinium-enhanced, T1-weighted magnetic resonance imaging (MRI) scan before treatment. (b) Axial, gadolinium-enhanced, T1-weighted MRI scan after initial treatment. (c) Axial, T2-weighted MRI scan taken 31 months after treatment. Arrowheads indicate the tumour.

Figure 1

Fig. 2Imaging studies for case two, showing coronal, gadolinium-enhanced, T1-weighted magnetic resonance imaging scans (a) before treatment and (b) after initial treatment. Arrowheads indicate the tumour.

Figure 2

Fig. 3Imaging studies for case three, showing axial, gadolinium-enhanced, T1-weighted magnetic resonance imaging scans (a) before treatment and (b) after initial treatment. Arrowheads indicate the tumour; arrows indicate an enlarged lymph node.

Figure 3

Fig. 4(a) Treatment outline for small cell lung carcinoma, as specified in the Japanese Lung Cancer Treatment Guidelines. (b) Proposed treatment outline for small cell carcinoma of the head and neck. (c) Chemoradiotherapy regimen for small cell carcinoma of the head and neck. LD = limited disease; ED = extensive disease; Cx = chemotherapy; CRT = chemoradiotherapy; CDDP = platinum; VP-16 = etoposide; Rx = radiotherapy; fr = fractions